Dimensional Fund Advisors LP Blueprint Medicines Corp Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 39,008 shares of BPMC stock, worth $3.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,008
Previous 31,979 21.98%
Holding current value
$3.53 Million
Previous $3.45 Million 4.64%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$84.1 - $120.5 $591,138 - $846,994
7,029 Added 21.98%
39,008 $3.61 Million
Q2 2024

Aug 09, 2024
SELL
$85.18 - $108.78 $1.42 Million - $1.81 Million
-16,619 Reduced 34.2%
31,979 $3.45 Million
Q1 2024

May 10, 2024
SELL
$73.17 - $99.79 $2.3 Million - $3.13 Million
-31,381 Reduced 39.24%
48,598 $4.61 Million
Q4 2023

Feb 07, 2024
SELL
$43.96 - $92.84 $4.03 Million - $8.51 Million
-91,684 Reduced 53.41%
79,979 $7.38 Million
Q3 2023

Nov 09, 2023
SELL
$46.9 - $66.0 $5.27 Million - $7.41 Million
-112,307 Reduced 39.55%
171,663 $8.62 Million
Q2 2023

Aug 09, 2023
SELL
$42.2 - $66.37 $1.02 Million - $1.6 Million
-24,131 Reduced 7.83%
283,970 $17.9 Million
Q1 2023

May 12, 2023
SELL
$37.97 - $50.0 $1.88 Million - $2.48 Million
-49,630 Reduced 13.87%
308,101 $13.9 Million
Q4 2022

Feb 09, 2023
SELL
$41.06 - $66.48 $3.15 Million - $5.1 Million
-76,725 Reduced 17.66%
357,731 $15.7 Million
Q3 2022

Nov 10, 2022
SELL
$49.93 - $77.7 $4.98 Million - $7.74 Million
-99,654 Reduced 18.66%
434,456 $28.6 Million
Q2 2022

Aug 12, 2022
SELL
$45.23 - $70.15 $921,335 - $1.43 Million
-20,370 Reduced 3.67%
534,110 $27 Million
Q1 2022

May 13, 2022
BUY
$54.1 - $110.08 $5.28 Million - $10.7 Million
97,557 Added 21.35%
554,480 $35.4 Million
Q4 2021

Feb 09, 2022
BUY
$94.25 - $115.99 $16.6 Million - $20.4 Million
175,896 Added 62.59%
456,923 $48.9 Million
Q3 2021

Nov 12, 2021
BUY
$80.98 - $109.47 $17.6 Million - $23.7 Million
216,778 Added 337.4%
281,027 $28.9 Million
Q2 2021

Aug 12, 2021
BUY
$82.78 - $101.0 $259,266 - $316,332
3,132 Added 5.12%
64,249 $5.65 Million
Q1 2021

May 14, 2021
SELL
$90.71 - $108.28 $521,128 - $622,068
-5,745 Reduced 8.59%
61,117 $5.95 Million
Q4 2020

Feb 25, 2021
BUY
$92.08 - $124.48 $6.16 Million - $8.32 Million
66,862 New
66,862 $7.5 Million

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email